Evaluation of circulating small extracellular vesicles derived miRNAs as biomarkers of early colon cancer: a comparison with plasma total miRNAs

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Bailey CE, Hu C-Y, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the USA, 1975-2010. JAMA Surg. 2015;150:17–17.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Chiba H, Takahashi A, Inamori M, et al. Early colon cancer presenting as intussusception and successfully treated using endoscopic submucosal dissection. Endoscopy. 2014;46(Suppl 1 UCTN):E326–327.
   Google Scholar
• Kiriyama S, Saito Y, Yamamoto S, et al. Comparison of endoscopic submucosal dissection with laparoscopic-assisted colorectal surgery for early-stage colorectal cancer: a retrospective analysis. Endoscopy. 2012;44:1024–1030.
   PubMed Web of Science ®Google Scholar
• Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993;25:455–461.
   PubMed Web of Science ®Google Scholar
• Fakih MG. Metastatic colorectal cancer: current state and future directions. J Clin Oncol. 2015;33:1809–1824.
   PubMed Web of Science ®Google Scholar
• Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi64–72.
   PubMed Web of Science ®Google Scholar
• Force USPST, Bibbins-Domingo K, Grossman DC, et al. Screening for Colorectal Cancer: US Preventive services task force recommendation statement. JAMA. 2016;315:2564–2575.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Ng SC, Chan FKL, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64:121–132.
   PubMed Web of Science ®Google Scholar
• Etheridge A, Lee I, Hood L, et al. Extracellular microRNA: A new source of biomarkers. Mutat Res. 2011;717:85–90.
   PubMed Web of Science ®Google Scholar
• Pratt AJ, MacRae IJ. The RNA-induced silencing complex: a versatile gene-silencing machine. J Biol Chem. 2009;284:17897–17901.
   PubMed Web of Science ®Google Scholar
• Gross N, Kropp J, Khatib H. MicroRNA Signaling in Embryo Development. Biology (Basel). 2017;6:34.
   Web of Science ®Google Scholar
• Yan R, Li K, Yuan D-W, et al. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. Int J Oncol. 2018;53:2566–2578.
   Web of Science ®Google Scholar
• Sun W, Fiorito S, Alessandri C, et al. MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway. Cell Death Dis. 2018;9:438.
   PubMed Web of Science ®Google Scholar
• Ji X, Wang E, Tian F. MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling. Biochem Biophys Res Commun. 2018;495:1342–1348.
   Web of Science ®Google Scholar
• Piwecka M, Glažar P, Hernandez-Miranda LR, et al. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science. 2017;357.
   PubMed Web of Science ®Google Scholar
• Vychytilova-Faltejskova P, Radova L, Sachlova M, et al. Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer. Carcinogenesis. 2016;37:941–950.
   PubMed Web of Science ®Google Scholar
• Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA. 2014;311:392–404.
   PubMed Web of Science ®Google Scholar
• Greystoke A, Ayub M, Rothwell DG, et al. al., Development of a circulating miRNA assay to monitor tumor burden: from mouse to man. Mol Oncol. 2016;10:282–291.
   Web of Science ®Google Scholar
• Ferracin M, Pedriali M, Veronese A, et al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J Pathol. 2011;225:43–53.
   PubMed Web of Science ®Google Scholar
• Kohlhapp FJ, Mitra AK, Lengyel E, et al. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene. 2015;34:5857–5868.
   Web of Science ®Google Scholar
• Challagundla KB, Fanini F, Vannini I, et al. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics. Expert Rev Mol Diagn. 2014;14:565–574.
   PubMed Web of Science ®Google Scholar
• An T, Qin S, Xu Y, et al. Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J Extracell Vesicles. 2015;4:27522.
   PubMed Web of Science ®Google Scholar
• Thind A, Wilson C. Exosomal miRNAs as cancer biomarkers and therapeutic targets. J Extracell Vesicles. 2016;5:31292.
   PubMed Web of Science ®Google Scholar
• Thery C. Cancer: diagnosis by extracellular vesicles. Nature. 2015;523:161–162.
   PubMed Web of Science ®Google Scholar
• Vlaeminck-Guillem V. Extracellular vesicles in prostate cancer carcinogenesis, diagnosis, and management. Front Oncol. 2018;8:222.
   PubMed Web of Science ®Google Scholar
• Ko J, Bhagwat N, Black T, et al. miRNA Profiling of Magnetic Nanopore-Isolated Extracellular Vesicles for the Diagnosis of Pancreatic Cancer. Cancer Res. 2018;78:3688–3697.
   PubMed Web of Science ®Google Scholar
• Sequeiros T, Rigau M, Chiva C, et al. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer. Oncotarget. 2017;8:4960–4976.
   PubMed Web of Science ®Google Scholar
• Buschmann D, Kirchner B, Hermann S, et al. Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing. J Extracell Vesicles. 2018;7:1481321.
   PubMed Web of Science ®Google Scholar
• Thery C, Amigorena S, Raposo G, et al. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. Chapter. 2006;3(Unit): 3–22.
   Google Scholar
• Consortium E-T, Van Deun J, Mestdagh P, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14:228–232.
   PubMed Web of Science ®Google Scholar
• Mateescu B, Kowal EJK, van Balkom BWM, et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper. J Extracell Vesicles. 2017;6:1286095.
   PubMed Web of Science ®Google Scholar
• Robinson MD, Oshlack A, Halsall JA, et al. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.
   PubMed Web of Science ®Google Scholar
• Mao X, Cai T, Olyarchuk JG, et al. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics. 2005;21:3787–3793.
   PubMed Web of Science ®Google Scholar
• Dueck A, Ziegler C, Eichner A, et al. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res. 2012;40:9850–9862.
   PubMed Web of Science ®Google Scholar
• Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
   PubMed Web of Science ®Google Scholar
• Kim HH, Kuwano Y, Srikantan S, et al. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 2009;23:1743–1748.
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025–1030.
   PubMed Web of Science ®Google Scholar
• Boyerinas B, Park S-M, Murmann AE, et al. Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1. Int J Cancer. 2012;130:1787–1797.
   PubMed Web of Science ®Google Scholar
• Gao Y, Meng H, Liu S, et al. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 2015;24:841–852.
   PubMed Web of Science ®Google Scholar
• Jusufovic E, Rijavec M, Keser D, et al. let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non–small–cell lung cancer. PLoS One. 2012;7:e45577.
   PubMed Web of Science ®Google Scholar
• Yang X, Cai H, Liang Y, et al. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells. Oncol Rep. 2015;33:1723–1730.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Hosokawa M, Matsumura J, et al. Effects of Zebularine on Invasion Activity and Intracellular Expression Level of let-7b in Colorectal Cancer Cells. Biol Pharm Bull. 2017;40:1320–1325.
   Web of Science ®Google Scholar
• Wong CC, Wong C-M, Tung EK-K, et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology. 2011;140:322–331.
   PubMed Web of Science ®Google Scholar
• Shen K, Liang Q, Xu K, et al. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol. 2012;84:320–330.
   PubMed Web of Science ®Google Scholar
• Yonemori M, Seki N, Yoshino H, et al. Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer. Cancer Sci. 2016;107:1233–1242.
   PubMed Web of Science ®Google Scholar
• Luo HN, Wang Z.H., Sheng Y, et al. MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol. 2014;31:789.
   PubMed Web of Science ®Google Scholar
• Shen K, Mao R, Ma L, et al. Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer. Febs J. 2014;281:3609–3624.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang M, Chen Q, et al. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma. Cancer Gene Ther. 2017;24:83–88.
   PubMed Web of Science ®Google Scholar
• Wu H, Xiao Z, Wang K, et al. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1. Biochem Biophys Res Commun. 2013;441:693–700.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Cai W-Y, Liu X-W, et al. Reverse correlation between MicroRNA-145 and FSCN1 affecting gastric cancer migration and invasion. PLoS One. 2015;10:e0126890.
   PubMed Web of Science ®Google Scholar
• Qin J, Wang F, Jiang H, et al. MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. Int J Clin Exp Pathol. 2015;8:1328–1340.
   PubMed Web of Science ®Google Scholar
• Gao F, Sun X, Wang L, et al. Downregulation of MicroRNA-145 caused by Hepatitis B Virus X protein promotes expression of CUL5 and contributes to Pathogenesis of Hepatitis B virus-associated hepatocellular carcinoma. Cell Physiol Biochem. 2015;37:1547–1559.
   PubMed Web of Science ®Google Scholar
• Campayo M, Navarro A, Viñolas N, et al. Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. Eur Respir J. 2013;41:1172–1178.
   Web of Science ®Google Scholar
• Wang RJ, Zheng YH, Wang P, et al. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int J Clin Exp Pathol. 2015;8:765–771.
   PubMed Web of Science ®Google Scholar
• Tang D, Shen Y, Wang M, et al. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer. Eur J Cancer Prev. 2013;22:540–548.
   PubMed Web of Science ®Google Scholar
• Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell. 2007;131:146–159.
   PubMed Web of Science ®Google Scholar
• Wu Q, Jin H, Yang Z, et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun. 2010;392:340–345.
   PubMed Web of Science ®Google Scholar
• Kim TH, Jeong J-Y, Park J-Y, et al. miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3. Oncotarget. 2017;8:72788–72800.
   Google Scholar
• Ma Y, Zhang P, Wang F, et al. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut. 2012;61:1447–1453.
   PubMed Web of Science ®Google Scholar
• Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010;127:118–126.
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WWS, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut. 2009;58:1375–1381.
   PubMed Web of Science ®Google Scholar
• Cheng H, Zhang L, Cogdell DE, et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One. 2011;6:e17745.
   PubMed Web of Science ®Google Scholar
• Castillo J, Bernard V, San Lucas FA, et al. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol. 2018;29:223–229.
   PubMed Web of Science ®Google Scholar
• Keerthikumar S, Chisanga D, Ariyaratne D, et al. ExoCarta: A Web-Based Compendium of Exosomal Cargo. J Mol Biol. 2016;428:688–692.
   PubMed Web of Science ®Google Scholar
• Santonocito M, Tobler KJ, Omurtag KR, et al. Molecular characterization of exosomes and their microRNA cargo in human follicular fluid: bioinformatic analysis reveals that exosomal microRNAs control pathways involved in follicular maturation. Fertil Steril. 2014;102(1751–1761):e1751.
   Web of Science ®Google Scholar
• Li SP, Lin ZX, Jiang XY, et al. Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools. Acta Pharmacol Sin. 2018;39:542–551.
   PubMed Web of Science ®Google Scholar
• Villarroya-Beltri C, Baixauli F, Gutierrez-Vazquez C, et al. Sorting it out: regulation of exosome loading. Semin Cancer Biol. 2014;28:3–13.
   PubMed Web of Science ®Google Scholar
• Janas T, Janas MM, Sapon K, et al. Mechanisms of RNA loading into exosomes. FEBS Lett. 2015;589:1391–1398.
   PubMed Web of Science ®Google Scholar